Identification of Hepatitis C Virus Inhibitors Targeting Different Aspects of Infection Using a Cell-Based Assay

Identification of the Niemann-Pick C1–like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor

(2012) Bruno Sainz et al.   NATURE MEDICINE

Synthesis and biological assay of 4-aryl-6-chloro-quinoline derivatives as novel non-nucleoside anti-HBV agents

(2011) Rui-Hua Guo et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Quinoline tricyclic derivatives. Design, synthesis and evaluation of the antiviral activity of three new classes of RNA-dependent RNA polymerase inhibitors

(2011) Antonio Carta et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Quinoline as a Privileged Scaffold in Cancer Drug Discovery

(2011) V. R. Solomon et al.   CURRENT MEDICINAL CHEMISTRY

(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry

(2011) Noémie Calland et al.   HEPATOLOGY

Proanthocyanidin-enriched extract from Myrothamnus flabellifolia Welw. exerts antiviral activity against herpes simplex virus type 1 by inhibition of viral adsorption and penetration

(2011) Kirsten Gescher et al.   JOURNAL OF ETHNOPHARMACOLOGY

EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy

(2011) Joachim Lupberger et al.   NATURE MEDICINE

Oligomeric proanthocyanidins from Rumex acetosa L. inhibit the attachment of herpes simplex virus type-1

(2010) Kirsten Gescher et al.   ANTIVIRAL RESEARCH

Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C

(2010) JIU-PING WANG et al.   APMIS

Multiple effects of silymarin on the hepatitis C virus lifecycle

(2010) Jessica Wagoner et al.   HEPATOLOGY

Role of N-Linked Glycans in the Functions of Hepatitis C Virus Envelope Proteins Incorporated into Infectious Virions

(2010) F. Helle et al.   JOURNAL OF VIROLOGY

Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity

(2010) M.R. Hutchinson et al.   NEUROSCIENCE

Assembly of infectious hepatitis C virus particles

(2010) Ralf Bartenschlager et al.   TRENDS IN MICROBIOLOGY

Hepatitis C virus experimental model systems and antiviral drug research

(2010) Susan L. Uprichard   VIROLOGICA SINICA

Development of a Cell-Based Hepatitis C Virus Infection Fluorescent Resonance Energy Transfer Assay for High-Throughput Antiviral Compound Screening

(2009) X. Yu et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Silibinin and Related Compounds Are Direct Inhibitors of Hepatitis C Virus RNA-Dependent RNA Polymerase

(2009) Abdelhakim Ahmed–Belkacem et al.   GASTROENTEROLOGY

Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA

(2009) Masahiko Takeshita et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Toll-Like Receptor 2 Senses Hepatitis C Virus Core Protein but Not Infectious Viral Particles

(2009) Marco Hoffmann et al.   Journal of Innate Immunity

The Tight Junction-Associated Protein Occludin Is Required for a Postbinding Step in Hepatitis C Virus Entry and Infection

(2009) I. Benedicto et al.   JOURNAL OF VIROLOGY

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

(2009) Alexander Ploss et al.   NATURE

Hepatitis C Virus Infection in Phenotypically Distinct Huh7 Cell Lines

(2009) Bruno Sainz et al.   PLoS One

Characterization of increased drug metabolism activity in dimethyl sulfoxide (DMSO)-treated Huh7 hepatoma cells

(2009) S. Choi et al.   XENOBIOTICA

Apolipoprotein B-dependent hepatitis C virus secretion is inhibited by the grapefruit flavonoid naringenin

(2008) Yaakov Nahmias et al.   HEPATOLOGY

Tight Junction Proteins Claudin-1 and Occludin Control Hepatitis C Virus Entry and Are Downregulated during Infection To Prevent Superinfection

(2008) S. Liu et al.   JOURNAL OF VIROLOGY

Skeletal Muscle Relaxants

(2008) Sharon See et al.   PHARMACOTHERAPY